WHY IT MATTERS: If you are a medical cannabis patient in Europe, Poland’s regulatory reversal and recovery is a reminder that access to your medication can be interrupted quickly by policy changes, making it essential to stay informed about local prescribing rules and maintain open communication with your physician. CLINICAL OVERVIEW: Poland’s medical cannabis market demonstrated resilience following a regulatory disruption that required patients to attend in-person consultations before receiving prescriptions, a policy shift that temporarily curtailed access for many patients who had relied on telemedicine pathways. The market’s recovery reflects both sustained patient demand and the adaptability of prescribing infrastructure when regulatory frameworks stabilize.